Brenner tumor: understanding and characteristics
Brenner tumor, also known as adenofibroma colloidal, adenofibroma pseudomucinous, adenofibroma ovarian, brenneroma, oophoroma, or fibroepithelioma mucinous benign, is a special type of tumor that often occurs in the ovaries. It was named after the German pathologist Friedrich Brenner, who first described this tumor in 1907.
A Brenner tumor is usually a small, solid tumor that may be unilateral or bilateral. It consists of epithelial (cover) cells surrounded by connective tissue. A characteristic feature of this tumor is the presence of cells with characteristic inclusions known as “encapsulated” Brenner cells. These inclusions have the appearance of colloidal or pseudomucinous formations.
Brenner tumor is usually benign and rarely becomes malignant. It can occur in women at any age, but is most often diagnosed in patients aged 40 to 60 years. This tumor usually does not cause symptoms and is discovered incidentally during other medical tests or surgeries.
However, in rare cases, Brenner tumor may cause symptoms such as lower abdominal pain, rumbling, an enlarged abdomen, or changes in urination. In such cases, additional tests such as ultrasound, computed tomography, or magnetic resonance imaging may be required to confirm the diagnosis and evaluate the characteristics of the tumor.
Treatment for Brenner tumor usually involves surgical removal of the tumor. In most cases, removal of the tumor itself is sufficient, while preserving the ovaries and uterus. In cases where the tumor is cancerous or aggressively growing, extensive surgery or additional treatment such as chemotherapy or radiation therapy may be required.
The prognosis for most patients with Brenner tumor is usually good, especially in cases of benign tumors. Regular monitoring with a doctor and following screening recommendations will help monitor the condition and promptly detect any changes or relapses.
In conclusion, Brenner tumor is a special type of tumor that is often found in the ovaries. It is usually benign and rarely becomes malignant. Surgical removal of the tumor is the mainstay of treatment, and the prognosis for most patients is usually good. Regular monitoring and screening will help monitor the condition and promptly detect any changes. Brenner tumor continues to be the subject of research, and further research will help expand our understanding of this tumor and improve diagnosis and treatment.